As Gene Editing Advances, Scientists Race to Set Boundaries
Around the world, leading scientific organizations are moving quickly to implement new guidelines to govern the use of gene editing.
genomics
Skeptics Unfairly Target UK Gene Sequencing Initiative
A new UK initiative has stirred debate about DNA analysis for healthy people. The program allows patients to pay to get their genome sequenced and analyzed if they agree to let the data be used...
Is Yeast the Future of Manufacturing?
A sweetener, based on natural sucrose, but that has no calories whatsoever? It's coming, along with portfolio of consumer products produced in the lab through synthetic genomics.
Genomic Study Offers Hope for Millions with Rare Diseases
A new study makes the case that genomic medicine can be cost effective in diagnosing rare diseases, offering a potential alternative path for millions of patients worldwide.
Canadian AI Needs More Commercial Successes
Toronto has been developing a base of world-class research since the 1980s and has become a hub for AI research over the past two years, but has been slow to effectively commercialize the effort.
Insurance Roadblocks Threaten to Limit Use of Genomic Tests
Resistance from insurance companies threatens to slow innovation that could dramatically improve patient outcomes from genomic testing.
Critical Genomic Breakthrough Should Help Identify Disease Risk
A new report suggests that an innovative method of analyzing DNA will allow medical researchers to predict disease risk for far more people than can be done with conventional medical tests.
Why I Joined a Research Study — and You Should Too
In which our intrepid reporter gives her very blood to stay on the front lines of modern healthcare.
Welcome to Precision Medicine (If You’re White)
Genomics helps tailor treatment for growing numbers of patients. But it works best for white people, who often already populate databases. How can it become valuable for everyone?
